Articles

These three potential M&A deals run the gamut from very possible to very unlikely, despite the benefits of a transaction getting done. More

Ginkgo Bioworks has tumbled this week, but Cathie Wood is among the key buyers of DNA stock, picking up shares yesterday. More

While Satixfy Communications certainly commands strong fundamental potential, SATX stock remains a high-risk proposition. More

Here's why investors may want to be careful with GRND stock following today's incredible momentum-driven rally. More

These are the best growth stocks to buy for 2023 with the business that they represent having potential catalysts. More

Although red ink can sometimes bring an opportunity for contrarianism, these (except one) market ideas represent stocks to sell. More

Novavax (NVAX) stock is on the move Friday after regulators in Canada approved the vaccine company's adult booster shot for Covid-19. More

Subscriber Sign in